BRCA1 and breast carcinoma: In a study of 876 women with BRCA1 and BRCA2 mutations, Choi et al found a decrease in breast cancer incidence in the first five years following RRBSO and a weaker but significant decrease in long-term risk for BRCA1 mutation carriers only [90].